96%Confidence
1Views
FDASource
2026-03-11Date
Summary
Yet another sterility recall for a Vista Meibo Tears product from Wizcure Pharmaa confirms widespread manufacturing quality failures at this facility. This pattern suggests systemic issues that could trigger an FDA import alert or broader regulatory action against the manufacturer.
Actionable: Advise healthcare providers and pharmacies to quarantine all Vista brand ophthalmic products from hi-health until manufacturing compliance is verified.
AI Confidence: 96%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-8
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now